Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms

    January 2021 in “ Skin appendage disorders ”
    Alfredo Rossi, Francesca Magri, Alvise Sernicola … Teresa Grieco
    Studysummary This study observed that telogen effluvium, or acute hair loss, often occurs 1 to 3 months after SARS-CoV-2 infection, earlier than classic telogen effluvium.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on karger.com →
    Discuss this study in the Community →

    Research cited in this study 9

    1. What Can Hair Tell Us About COVID-19? Experimental Dermatology · 2020
    2. Telogen Effluvium: A Sequela of COVID-19 International Journal of Dermatology · 2020
    3. Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience Dermatologic Therapy · 2020
    4. Acute Telogen Effluvium Associated with SARS-CoV-2 Infection AJGP · 2020
    5. Evaluation of the Effects of COVID-19 Pandemic on Hair Diseases Through a Web-Based Questionnaire Dermatologic Therapy · 2020
    6. Management of Telogen Effluvium During the COVID-19 Emergency: Psychological Implications Dermatologic Therapy · 2020
    7. Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells Frontiers in Cellular and Infection Microbiology · 2018
    8. Telogen Effluvium Due to Recombinant Interferon Alpha-2b Dermatology · 2009
    9. Interleukin-1β Is Differentially Expressed by Human Dermal Papilla Cells in Response to PKC Activation and Is a Potent Inhibitor of Human Hair Follicle Growth in Organ Culture Journal of interferon & cytokine research · 1997